PBLA logo

Panbela Therapeutics (PBLA) Return On Equity

Annual ROE

536.37%
+102.37%+23.59%

December 31, 2023


Summary


Performance

PBLA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBLAprofitabilitymetrics:

Quarterly ROE

304.71%
-240.74%-44.14%

September 30, 2024


Summary


Performance

PBLA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBLAprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

PBLA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.6%+100.4%
3 y3 years+1050.3%-61.0%
5 y5 years+124.3%-61.0%

PBLA ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+640.4%-89.7%+100.4%
5 y5-yearat high+219.8%-89.7%+100.4%
alltimeall timeat high+124.3%-90.0%+100.4%

Panbela Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
304.71%(-44.1%)
Jun 2024
-
545.45%(-72.1%)
Mar 2024
-
1955.03%(-102.8%)
Dec 2023
536.37%(+23.6%)
-70.14 K%(-2482.9%)
Sep 2023
-
2943.60%(+229.5%)
Jun 2023
-
893.47%(+14.4%)
Mar 2023
-
781.06%(-18.5%)
Dec 2022
434.00%(-537.3%)
958.05%(-126.1%)
Sep 2022
-
-3670.95%(+641.1%)
Jun 2022
-
-495.33%(+288.3%)
Mar 2022
-
-127.57%(+17.1%)
Dec 2021
-99.25%(+75.9%)
-108.96%(+29.2%)
Sep 2021
-
-84.36%(-5.1%)
Jun 2021
-
-88.86%(+15.5%)
Mar 2021
-
-76.92%(-18.0%)
Dec 2020
-56.44%(-87.4%)
-93.85%(-36.0%)
Sep 2020
-
-146.69%(-51.0%)
Jun 2020
-
-299.44%(-48.9%)
Mar 2020
-
-585.89%(-27.5%)
Dec 2019
-447.65%(-79.7%)
-808.08%(-33.9%)
Sep 2019
-
-1222.54%(-154.2%)
Jun 2019
-
2254.14%(-26.1%)
Mar 2019
-
3048.40%(+220.7%)
Dec 2018
-2203.36%
950.56%(+109.0%)
DateAnnualQuarterly
Sep 2018
-
454.84%(+19.4%)
Jun 2018
-
381.00%(+31.9%)
Mar 2018
-
288.96%(-55.4%)
Dec 2017
281.21%(+155.4%)
647.43%(+14.0%)
Sep 2017
-
567.76%(+20.7%)
Jun 2017
-
470.29%(+24.5%)
Mar 2017
-
377.79%(+163.7%)
Dec 2016
110.12%(-40.1%)
143.28%(+22.4%)
Sep 2016
-
117.08%(-4.7%)
Jun 2016
-
122.91%(-26.2%)
Mar 2016
-
166.61%(-54.9%)
Dec 2015
183.77%(-31.5%)
369.59%(-29.2%)
Sep 2015
-
521.75%(-44.4%)
Jun 2015
-
938.84%(+22.0%)
Mar 2015
-
769.37%(+86.7%)
Dec 2014
268.31%(+74.5%)
412.09%(-19.4%)
Sep 2014
-
510.98%(+311.7%)
Jun 2014
-
124.12%(-22.2%)
Mar 2014
-
159.56%(-14.5%)
Dec 2013
153.73%(-125.4%)
186.61%(+128.2%)
Sep 2013
-
81.76%(-197.0%)
Jun 2013
-
-84.28%(-73.6%)
Mar 2013
-
-318.83%(-47.4%)
Dec 2012
-606.37%(-1875.6%)
-606.37%
Dec 2011
34.15%
-

FAQ

  • What is Panbela Therapeutics annual return on equity?
  • What is the all time high annual ROE for Panbela Therapeutics?
  • What is Panbela Therapeutics annual ROE year-on-year change?
  • What is Panbela Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Panbela Therapeutics?
  • What is Panbela Therapeutics quarterly ROE year-on-year change?

What is Panbela Therapeutics annual return on equity?

The current annual ROE of PBLA is 536.37%

What is the all time high annual ROE for Panbela Therapeutics?

Panbela Therapeutics all-time high annual return on equity is 536.37%

What is Panbela Therapeutics annual ROE year-on-year change?

Over the past year, PBLA annual return on equity has changed by +102.37% (+23.59%)

What is Panbela Therapeutics quarterly return on equity?

The current quarterly ROE of PBLA is 304.71%

What is the all time high quarterly ROE for Panbela Therapeutics?

Panbela Therapeutics all-time high quarterly return on equity is 3048.40%

What is Panbela Therapeutics quarterly ROE year-on-year change?

Over the past year, PBLA quarterly return on equity has changed by +70.45 K% (+100.43%)